Market closed

Bausch Health/$BHC

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Bausch Health

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Ticker

$BHC

Sector

Health Care

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Laval, Canada

Employees

20,270

Website

www.bauschhealth.com

Bausch Health Metrics

BasicAdvanced

$2.7B

-

-$0.48

0.77 -

Price and volume

Market cap

$2.7B

Beta

0.77

52-week high

$11.46

52-week low

$3.96

Average daily volume

1.3M

Financial strength

Current ratio

1.188

Quick ratio

0.624

Long term debt to equity

-8,700

Total debt to equity

-8,887.19

Interest coverage (TTM)

1.26%

Management effectiveness

Return on assets (TTM)

4.15%

Return on equity (TTM)

90.99%

Valuation

Price to revenue (TTM)

0.287

Price to book

-2.32

Price to tangible book (TTM)

-0.15

Price to free cash flow (TTM)

2.694

Growth

Revenue change (TTM)

10.91%

Earnings per share change (TTM)

-81.69%

3-year revenue growth (CAGR)

3.88%

3-year earnings per share growth (CAGR)

-47.10%

What the Analysts think about Bausch Health

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Bausch Health stock.

Bausch Health Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Bausch Health Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Bausch Health News

AllArticlesVideos

Bausch + Lomb CEO on the negative impact of screen time on eye health

CNBC Television·9 hours ago

Bausch and Lomb CEO: Right on track with our important initiatives

CNBC Television·11 hours ago

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America

GlobeNewsWire·2 days ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BHC

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bausch Health stock?

Bausch Health (BHC) has a market cap of $2.7B as of January 15, 2025.

What is the P/E ratio for Bausch Health stock?

The price to earnings (P/E) ratio for Bausch Health (BHC) stock is 0 as of January 15, 2025.

Does Bausch Health stock pay dividends?

No, Bausch Health (BHC) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Bausch Health dividend payment date?

Bausch Health (BHC) stock does not pay dividends to its shareholders.

What is the beta indicator for Bausch Health?

Bausch Health (BHC) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.